The Future of Early Cancer Detection is Coming

Quantgene Serenity™ is a system to help guide your physician in early cancer detection. Serenity enables your doctor to screen for multiple forms of cancer from just one blood draw.

Innovative Early Detection Technology

Serenity combines precision sequencing with artificial intelligence to detect very small traces of cancer-related mutations in the blood. This is a new way to screen for cancer using cell-free DNA (cfDNA) from a simple blood draw.

Clinical Validation

Serenity has been studied in one of the largest cfDNA clinical trials across 15 cancer types and 13 leading oncology centers in the US, Germany and Switzerland.

Delivered By Experts

Expert physician support is at the core of Serenity. From answering questions to interpreting your results, Serenity is by your side.

The Future of Early Cancer Detection is Coming

Quantgene Serenity™ is a system to help guide your physician in early cancer detection. Serenity enables your doctor to screen for multiple forms of cancer from just one blood draw.

Innovative Early Detection Technology

Serenity combines precision sequencing with artificial intelligence to detect very small traces of cancer-related mutations in the blood. This is a new way to screen for cancer using cell-free DNA (cfDNA) from a simple blood draw.

Clinical Validation

Serenity has been studied in one of the largest cfDNA clinical trials across 15 cancer types and 13 leading oncology centers in the US, Germany and Switzerland.

Delivered By Experts

Expert physician support is at the core of Serenity. From answering questions to interpreting your results, Serenity is by your side.

The Best Protection Against Cancer is Detecting it Early

Today, most cancers are detected in later stages when patients have symptoms, and cancer may have already spread in the body [1]. At this point, cancer is harder to treat and chances of survival are lower [2].

Stay Informed

The Best Protection Against Cancer is Detecting it Early

Today, most cancers are detected in later stages when patients have symptoms, and cancer may have already spread in the body [3]. At this point, cancer is harder to treat and chances of survival are lower [4].

Stay Informed
"Finding cancer at its earliest, most treatable stage gives patients the greatest chance of survival."
- American cancer Society [3]

Cancer May Be a Risk
Despite Your Best Efforts

Each day you do your best to keep you and your family safe and healthy. But there are still risks that feel out of your hands like the possibility of cancer.
‍
Each one of us has a 38.6% chance of developing cancer; it is the second most common cause of death in the US [4].

Detecting cancer mutations early is the key to ensuring more effective and successful treatment. People who have known genetic risk factors for cancer need a solution that can help them be proactive about regular screening. If you have a genetic mutation like BRCA1, BRCA2, BARD1, CDH1, and CHEK2 Serenity may be a useful tool for your doctor to monitor you for active cancer mutations through a routine blood draw.

Stay Informed

Cancer May Be a Risk
Despite Your Best Efforts

Each day you do your best to keep you and your family safe and healthy. But there are still risks that feel out of your hands like the possibility of cancer.
‍
Each one of us has a 38.6% chance of developing cancer; it is the second most common cause of death in the US [1].

Detecting cancer mutations early is the key to ensuring more effective and successful treatment. People who have known genetic risk factors for cancer need a solution that can help them be proactive about regular screening. If you have a genetic mutation like BRCA1, BRCA2, BARD1, CDH1, and CHEK2 Serenity may be a useful tool for your doctor to monitor you for active cancer mutations through a routine blood draw.

Stay Informed

Current Screening Options Can Fall Short

While some advances have been made, standard cancer screening methods like colonoscopies or mammograms can be invasive, costly and are not always able to detect cancer at its earliest stages. And for some common cancers, there is no screening option available at all [5]. 
‍
Even hereditary DNA tests can only provide the likelihood of cancer based on your genetic make-up, but they can’t tell you the range of cancer-related mutations that are present in your body at this moment [6].

Stay Informed

Detect Cancer Early
with a Single Blood Draw

Finding cancer early gives patients the highest chance of survival. Serenity allows physicians to screen for multiple forms of cancer without dangerous, invasive procedures. The technology has been studied in one of the most extensive cell-free-DNA trials in leading oncology centers, and its laboratory process is undergoing CLIA approval for clinical use. Everything from answering your questions to interpreting your results is backed by expert physician support.
‍
Sign up now to stay informed and be first to learn when Serenity is available, planned for 2020.

Stay Informed

Detect Cancer Early
with a Single Blood Draw

Finding cancer early gives patients the highest chance of survival. Serenity allows physicians to screen for multiple forms of cancer without dangerous, invasive procedures. The technology has been studied in one of the most extensive cell-free-DNA trials in leading oncology centers, and its laboratory process is undergoing CLIA approval for clinical use. Everything from answering your questions to interpreting your results is backed by expert physician support.
‍
Sign up now to stay informed and be first to learn when Serenity is available, planned for 2020.

Stay Informed

Be the First to Know when Serenity is Available

Serenity is coming soon so you can finally take your health into your own hands.

Sign Up

References

1. Take Action, 2019, Canary Foundation, accessed 12/13/2019, <https://www.canaryfoundation.org>
2. Report Outlines the Future Potential of Cancer Screenings, 12/5/2019, American Cancer Society, accessed 12/13/2019, <https://www.cancer.org>
3. Cancer Treatment and Survivorship Facts & Figures 2019-2021, 1/1/2019, American Cancer Society, accessed 12/13/2019, <https://www.cancer.org>
4. Lifetime Risk of Developing or Dying From Cancer, 1/4/2018, American Cancer Society, accessed 12/13/2019, <https://www.cancer.org>
5. Cancer Prevention and Early Detection Facts and Figures 2019-2020, 1/1/2019, American Cancer Society, accessed 12/13/2019, <https://www.cancer.org>
6. What are the risks and limitations of genetic testing?, 12/10/2019, National Institute of Health; U.S. National Library of Medicine, accessed 12/13/2019, <https://ghr.nlm.nih.gov>

2940 Nebraska Ave
Santa Monica, CA 90404
(424) 272-1566


COPYRIGHT © QUANTGENE 2020